Pentwater Capital Management’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-69,050,000
| Closed | -$47.7M | – | 363 |
|
|
2020
Q4 | $47.7M | Buy |
69,050,000
+30,983,188
| +81% | +$21.4M | 0.58% | 23 |
|
|
2020
Q3 | $85.7M | Sell |
38,066,812
-15,478,000
| -29% | -$34.8M | 1.11% | 17 |
|
|
2020
Q2 | $192M | Buy |
53,544,812
+535,000
| +1% | +$1.92M | 3.41% | 6 |
|
|
2020
Q1 | $201M | Buy |
53,009,812
+17,456,000
| +49% | +$66.3M | 3.33% | 7 |
|
|
2019
Q4 | $107M | Buy |
+35,553,812
| New | +$107M | 1.75% | 9 |
|